|
시장보고서
상품코드
2148353
청신경 종양 시장 : 질환 유형별, 치료 유형별, 진단별, 종양 크기별, 최종사용자별, 지역별Acoustic Neuroma Market, By Disease Type, By Treatment Type, By Diagnosis, By Tumor Size, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
청신경 종양 시장은 2026년에 20억 4,000만 달러 규모로 추정되며, 2033년까지 33억 7,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 7.4%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 20억 4,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간의 CAGR: | 7.40% | 2033년 시장 규모 예측: | 33억 7,000만 달러 |
청신경 종양(전정 슈반세포종)은 전정-달팽이관 신경에 발생하는 양성 종양으로, 천천히 성장하며 주로 청각과 평형 감각에 영향을 미칩니다. 전 세계 청신경 종양 시장은 영상 진단, 현미경 수술, 정위 방사선 수술, 방사선 치료, 경과 관찰 및 제한적인 약물 치료로 구성되어 있으며, MRI 및 최소침습 시술의 발전으로 인해 보다 신속하고 맞춤형 치료가 가능해졌습니다.
세계 청신경 종양 시장은 뇌신경외과 전문의, 이비인후과 전문의, 방사선 종양학 전문의의 전문화가 진행되고 있으며, 희귀 신경 질환에 대한 인식이 높아짐에 따라 성장하고 있습니다. 신경학 연구, 첨단 신경 영상 진단 및 정밀 치료 기술에 대한 투자 증가가 전 세계적으로 청신경 종양 의 진단 및 치료 솔루션 도입을 촉진할 것으로 예상됩니다.
시장 역학
세계 청신경 종양 시장은 첨단 MRI를 통한 청신경 종양 탐지 정확도의 향상, 전정 장애에 대한 인식 제고, 그리고 감마나이프나 사이버나이프와 같은 최소침습 치료법의 보급에 힘입어 성장하고 있습니다. 또한, 의료비 증가, 전문적인 신경 의료 서비스 제공, 그리고 첨단 치료 기술 활용 기회의 확대가 시장 성장을 더욱 뒷받침하고 있습니다.
그러나 높은 치료비, 전문 의료 서비스에 대한 접근 제한, 청력 손실 및 안면 신경 합병증과 같은 위험 등 시장에 몇 가지 제약요인이 존재합니다. 그럼에도 불구하고, AI를 활용한 신경 영상 진단, 신흥 시장의 의료 인프라 확충, 그리고 표적 약물 요법에 대한 연구에는 큰 기회가 존재합니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 규명하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 해설하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 청신경 종양 시장의 주요 기업 개요를 분석하고 있습니다.
- 본 보고서에서 얻은 인사이트를 바탕으로 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- 본 ‘전 세계 청신경 종양 시장 보고서’는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 청신경 종양 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 원활하게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 청신경 종양 시장 : 질환 유형별, 2021-2033년
제5장 세계의 청신경 종양 시장 : 치료 유형별, 2021-2033년
제6장 세계의 청신경 종양 시장 : 진단별, 2021-2033년
제7장 세계의 청신경 종양 시장 : 종양 크기별, 2021-2033년
제8장 세계의 청신경 종양 시장 : 최종사용자별, 2021-2033년
제9장 세계의 청신경 종양 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고문헌 및 조사 방법
KSM 26.10.22Acoustic Neuroma Market is estimated to be valued at USD 2.04 Bn in 2026 and is expected to reach USD 3.37 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.04 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.40% | 2033 Value Projection: | USD 3.37 Bn |
Acoustic neuroma or vestibular schwannoma is a benign tumor of the vestibulocochlear nerve, which slowly grows and mainly affects hearing and balance. The global acoustic neuroma market comprises diagnostic imaging, microsurgery, stereotactic radiosurgery, radiotherapy, observation, and limited drug therapies, wherein advances in MRI and minimally invasive procedures have facilitated faster and more personalized treatment.
The global acoustic neuroma market is driven by increasing specialization among neurosurgeons, otolaryngologists and radiation oncologists, and growing awareness about rare neurological disorders. Increasing investments in neurological research, advanced neuroimaging and precision treatment technologies are expected to fuel the adoption of the acoustic neuroma diagnosis and treatment solutions worldwide.
Market Dynamics
The global acoustic neuroma market is driven by the enhanced detection of acoustic neuroma with advanced MRI, growing awareness about vestibular disorders, and increasing adoption of minimally invasive treatments such as Gamma Knife and CyberKnife radiosurgery. Furthermore, increasing healthcare expenditure, specialized neurological care and better availability of advanced treatment technologies further bolster market growth.
However, a number of constraints are present in the market, such as high treatment costs, limited access to specialized care, and risks such as hearing loss and facial nerve complications. Nevertheless, significant opportunities exist in AI-enabled neuroimaging, healthcare infrastructure expansion across emerging markets, and research into targeted drug therapies.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global acoustic neuroma market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Elekta AB, Accuray Incorporated, Siemens Healthineers AG, GE HealthCare Technologies Inc., Natus Medical Incorporated, Canon Medical Systems Corporation, Medtronic plc, Brainlab AG, Stryker Corporation, and Carl Zeiss Meditec AG
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global acoustic neuroma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acoustic neuroma market
Market Segmentation
- Disease Type Insights (Revenue, USD Bn, 2021 - 2033)
- Sporadic Acoustic Neuroma
- Neurofibromatosis Type 2-Associated Acoustic Neuroma
- Treatment Type Insights (Revenue, USD Bn, 2021 - 2033)
- Microsurgical Resection
- Stereotactic Radiosurgery
- Fractionated Radiotherapy
- Observation / Watchful Waiting
- Drug Therapy
- Diagnosis Insights (Revenue, USD Bn, 2021 - 2033)
- Magnetic Resonance Imaging (MRI)
- Audiometry
- Vestibular Testing
- Others
- Tumor Size Insights (Revenue, USD Bn, 2021 - 2033)
- Small Tumors
- Medium Tumors
- Large Tumors
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Academic and Research Institutes
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Elekta AB
- Accuray Incorporated
- Siemens Healthineers AG
- GE HealthCare Technologies Inc.
- Natus Medical Incorporated
- Canon Medical Systems Corporation
- Medtronic plc
- Brainlab AG
- Stryker Corporation
- Carl Zeiss Meditec AG
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Acoustic Neuroma Market, By Disease Type
- Global Acoustic Neuroma Market, By Treatment Type
- Global Acoustic Neuroma Market, By Diagnosis
- Global Acoustic Neuroma Market, By Tumor Size
- Global Acoustic Neuroma Market, By End User
- Global Acoustic Neuroma Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Disease Type Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Industry Trends
4. Global Acoustic Neuroma Market, By Disease Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Sporadic Acoustic Neuroma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Neurofibromatosis Type 2-Associated Acoustic Neuroma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Acoustic Neuroma Market, By Treatment Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Microsurgical Resection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Stereotactic Radiosurgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Fractionated Radiotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Observation / Watchful Waiting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Drug Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Acoustic Neuroma Market, By Diagnosis, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Magnetic Resonance Imaging (MRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Audiometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Vestibular Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Acoustic Neuroma Market, By Tumor Size, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Small Tumors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Medium Tumors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Large Tumors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Acoustic Neuroma Market, By End User, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
9. Global Acoustic Neuroma Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Tumor Size, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Tumor Size, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Tumor Size, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Tumor Size, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Tumor Size, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Tumor Size, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Elekta AB
- Company Highlights
- Disease Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Accuray Incorporated
- Company Highlights
- Disease Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers AG
- Company Highlights
- Disease Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE HealthCare Technologies Inc.
- Company Highlights
- Disease Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Natus Medical Incorporated
- Company Highlights
- Disease Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Canon Medical Systems Corporation
- Company Highlights
- Disease Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic plc
- Company Highlights
- Disease Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Brainlab AG
- Company Highlights
- Disease Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Stryker Corporation
- Company Highlights
- Disease Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Carl Zeiss Meditec AG
- Company Highlights
- Disease Type Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
